Plain-English translation of NCT07152639 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new diagnostic skin test called EEC that doctors hope will better detect tuberculosis infection. Researchers will compare this new test to existing skin tests and blood tests in people of different ages—some who have tuberculosis, some who are healthy, and some with other lung diseases. The goal is to see if EEC is as good as or better than current tests at identifying who has tuberculosis infection.
Current tests for tuberculosis infection have limitations—some don't work well in certain age groups, and others can give false results. This medication aims to provide doctors with a more reliable and consistent way to diagnose tuberculosis infection across all ages.
You likely qualify if…
You likely don't qualify if…
Depending on which study group you join, you will receive one or two small intradermal skin test injections on your forearm using a standard skin test method. The injections will be given at least 30 minutes apart on different arms. You will then need to return for follow-up visits so doctors can measure and record your skin reaction. The entire process takes place over a few weeks, with the main observation period based on when your second injection is given.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China